6676.TWO Sunny Pharmtech Inc.

Healthcare Biotechnology Taiwan OTC Exchange
6.98 TWD
Close of Nov 6, 2026
6.93 19.10
Market cap
TWD 1.18B
P/E
-
P/B
1.64x
ROE
-74.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.

Is 6676.TWO undervalued?

Graham number

The Graham number of Sunny Pharmtech Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sunny Pharmtech Inc. fundamental analysis

No fundamental analysis for Sunny Pharmtech Inc. yet.

Sunny Pharmtech Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sunny Pharmtech Inc.

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug formulations and raw materials in Taiwan, the United States, and internationally. It offers lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrof…

Full company profile